Journal of Clinical Pathology · 1991 · 36 citations · 6 references
MedicineMolecular BiologyOncologyBreast OncologyMolecular OncologyOncogenesBreast Cancer OncologyBreast PathologyMale Breast CancerMalignant NeoplasmsOncogenic Signaling PathwaysTumor AntigensBreast Cancer HistopathologyBreast Cancer Molecular SubtypesMale Breast PathologyMale Breast TumorsMalignant Breast Tumors
A series of 21 male breast carcinomas were immunostained using NCL-CB11, an antibody directed against the internal domain of the c-erbB-2 transmembrane oncoprotein. In contrast to female breast cancer, where up to 35% of cases show positivity, all of these cases were negative. This suggests that no prognostic information regarding patient survival can be made in these patients and that male breast carcinomas may be under different growth control mechanisms from female breast carcinomas.
6
c-erbB-2 oncoprotein expression in primary human tumors
Amanda McCann, P. Dervan, Paul A. Johnston et al. · Cancer · 1990 · 138 citations
Ian Corbett, James A. Henry, Brian Angus et al. · The Journal of Pathology · 1990 · 108 citations
Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
Nicholas H. Heintz, Kimberly Leslie, L. A. Rogers et al. · PubMed · 1990 · 95 citations